When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Polycystic ovary syndrome

Последний просмотренный: 16 Sep 2025
Last updated: 16 Oct 2025

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • female of reproductive age
  • irregular menstruation
  • infertility
  • hirsutism
Полная информация

Другие диагностические факторы

  • acne
  • overweight or obesity
  • hypertension
  • scalp hair loss
  • oily skin or excessive sweating
  • acanthosis nigricans
Полная информация

Факторы риска

  • family history of PCOS
  • premature adrenarche
  • obesity
  • low birth weight
  • fetal androgen exposure
  • environmental endocrine disruptors
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • serum 17-hydroxyprogesterone
  • serum prolactin
  • serum thyroid-stimulating hormone
  • oral glucose tolerance test
  • fasting lipid panel
Полная информация

Исследования, проведение которых нужно рассмотреть

  • serum total and free testosterone
  • serum dehydroepiandrosterone sulfate (DHEAS)
  • serum androstenedione
  • pelvic ultrasound
  • serum anti-Mullerian hormone
  • basal body temperature monitoring
  • luteal phase progesterone measurement
  • serum LH and follicle-stimulating hormone (FSH)
  • hemoglobin A1c or fasting plasma glucose
Полная информация

Алгоритм лечения

Острый

with infertility and desiring fertility

ПРОДОЛЖЕНИЕ

not desiring current fertility

Составители

Авторы

Mark O. Goodarzi, MD, PhD
Mark O. Goodarzi

Division of Endocrinology, Diabetes & Metabolism

Eris M. Field Chair in Diabetes Research

Professor of Medicine

Cedars-Sinai Medical Center

Los Angeles

CA

Раскрытие информации

MOG has been reimbursed for one-time participation in an advisory board for Nestle Health Science on the topic of exocrine pancreatic dysfunction. MOG is an author of a number of references cited in this topic.

Рецензенты

Antoni Duleba, MD

Professor

Department of Obstetrics and Gynecology

University of California Davis

Sacramento

CA

Раскрытие информации

AD declares that he has no competing interests.

Richard S. Legro, MD

Professor

Department of Obstetrics and Gynecology

Penn State Hershey College of Medicine

Hershey

PA

Раскрытие информации

RSL has been reimbursed by Serono for attending a medical conference and received a lecture fee, and has consulted for Ferring. He has received research funding from the NIH, the Commonwealth of Pennsylvania, and Parke Davis. He is an author of a number of references cited in this topic.

Cornelis B. (Nils) Lambalk, MD, PhD

Gynaecologist/Fertility Specialist

Division of Reproductive Medicine

Department of Obstetrics and Gynaecology

VU University Medical Centre

Amsterdam

The Netherlands

Раскрытие информации

CBL declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016 Aug 11;2:16057. Аннотация

Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-69.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности